Article
MRE11 as a molecular signature and therapeutic target for cancer treatment with radiotherapy
20 May 2021
Abstract excerpt
MRE11, the core of the MRE11/RAD50/NBS1 complex, is one of key DNA damage response proteins. Increasing evidence suggests that its expression in cancer cells is critical to developing radioresistance; as such, MRE11 is an emerging marker for targeted radiosensitization strategies. Elevated MRE11 in tumor tissues has been associated with poor survival in patients undergoing radiotherapy, although in some cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
